🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementGallbladder disease risk — cholelithiasis data from clinical trials Page 3

Gallbladder disease risk — cholelithiasis data from clinical trials

PharmacoVig_BOS Sun, Jun 7, 2026 at 12:51 PM 12 replies 266 viewsPage 3 of 3
mel_PDX
Member
189
890
Dec 2024
Portland, OR
Jun 8, 2026 at 7:52 AM#11
Dr.SurgeonPGH said:
The gap between trial results and real-world results is consistent and it is not fraud.

Bookmarking. The distinction being drawn above is the one nobody else makes. Sending this to two other people who asked me the same thing last week.

Last edited: Jun 8, 2026 at 1:52 PM
14 12Dr.NateNeph, PharmD_Rodriguez, julia.endo and 11 others
Reply Quote Save Share Report
Dr.LipidDallas
VIP Member
2,678
14,567
Dec 2023
Dallas, TX
Jun 8, 2026 at 11:12 AM#12

Adding the clinical framing, because it changes how the question reads.

Gallbladder ultrasound monitoring on gallbladder risk: given the known gallstone risk with rapid weight loss, my doctor orders gallbladder ultrasound every 6 months:

Baseline: normal, no stones or sludge
Month 6: small amount of biliary sludge, no stones
Month 12: sludge resolved, gallbladder normal

Ursodeoxycholic acid (Ursodiol) 300mg BID was prescribed prophylactically from the start. This reduces gallstone formation during rapid weight loss by ~60% per the available data. Ask your doctor about prophylactic ursodiol if you're losing weight rapidly.

15 13wei_SG, cory_ATX, lori_vegas and 12 others
Reply Quote Save Share Report
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
Jun 8, 2026 at 2:32 PM#13
Dr.CardioMD said:
Read four things before the headline number.

I am going to disagree with the direction of travel here. The thread has converged on the tidiest answer rather than the best-supported one, and those are not the same thing.

16 14Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 13 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Jun 8, 2026 at 5:51 PM#14

One concrete data point for the thread. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

17 15cory_ATX, lori_vegas, Dr.PulmRoch and 14 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jun 8, 2026 at 9:11 PM#15

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source.

18 16PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 15 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
Fatigue on semaglutide — caloric deficit vs direct drug effect25 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register